Physician
Anderson, Michelle
Anderson, Michelle was paid $62K by Medicaid between Aug 2022 and Mar 2023, across 8 billing codes. Its largest line is 87637, Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV — 33% of everything it billed.
33Billing provider infoANDERSON, MICHELLE
WAREHAM, MA 02571
WAREHAM, MA 02571
33aNPI1205022654assigned 09/19/2007
33bProvider typePediatrics Physician
28Total paid$62K
24GClaims963
24DCodes billed8
24AFirst – last monthAug 2022 – Mar 2023
Compared with peers
Next to other Pediatrics Physician providers in Massachusetts
Rank by total paid#467 of 1,273
Median peer was paid$24K
This provider vs. median2.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 502 | $29K | |
| 2023 | 461 | $33K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 33% | 144 | 142 | $21K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 28% | 154 | 151 | $17K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 23% | 252 | 247 | $15K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 6.0% | 159 | 157 | $4K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 5.5% | 111 | 109 | $3K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.8% | 34 | 34 | $2K |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 1.2% | 82 | 82 | $742.10 |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 27 | 27 | $277.29 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.